{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:51:05Z","timestamp":1778687465052,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00663-8","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T01:53:13Z","timestamp":1758246793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assembling of phenyl substituted halogens in the C3-position of substituted isatins by mono wave assisted synthesis: development of a new class of monoamine oxidase inhibitors"],"prefix":"10.1007","volume":"39","author":[{"given":"Della Grace Thomas","family":"Parambi","sequence":"first","affiliation":[]},{"given":"Stephanus J.","family":"Cloete","sequence":"additional","affiliation":[]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[]},{"given":"Tariq Ghazi","family":"Alsahli","sequence":"additional","affiliation":[]},{"given":"Arafa","family":"Musa","sequence":"additional","affiliation":[]},{"given":"Sumera","family":"Qasim","sequence":"additional","affiliation":[]},{"given":"Muzammil","family":"Kabier","sequence":"additional","affiliation":[]},{"given":"Sachithra Thazhathuveedu","family":"Sudevan","sequence":"additional","affiliation":[]},{"given":"Saranya Kattil","family":"Parmbil","sequence":"additional","affiliation":[]},{"given":"An\u00e9l","family":"Petzer","sequence":"additional","affiliation":[]},{"given":"Jacobus P.","family":"Petzer","sequence":"additional","affiliation":[]},{"given":"Bijo","family":"Mathew","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"663_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117159","volume":"283","author":"S Sblano","year":"2025","unstructured":"Sblano S, Boccarelli A, Deruvo C et al (2025) The potential of MAO inhibitors as chemotherapeutics in cancer: a literature survey. Eur J Med Chem 283:117159. https:\/\/doi.org\/10.1016\/j.ejmech.2024.117159","journal-title":"Eur J Med Chem"},{"key":"663_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13765-023-00823-0","volume":"66","author":"AT Peedikayil","year":"2023","unstructured":"Peedikayil AT, Lee J, Abdelgawad MA et al (2023) Inhibitions of monoamine oxidases by ferulic acid hydrazide derivatives: synthesis, biochemistry, and computational evaluation. Appl Biol Chem 66:66. https:\/\/doi.org\/10.1186\/s13765-023-00823-0","journal-title":"Appl Biol Chem"},{"issue":"1","key":"663_CR3","doi-asserted-by":"publisher","first-page":"23399","DOI":"10.1021\/acsomega.1c03250","volume":"6","author":"S Kumar","year":"2021","unstructured":"Kumar S, Nair AS, Bhashkar V, Sudevan ST, Koyiparambath VP, Khames A, Abdelgawad MA, Mathew B (2021) Navigating into the chemical space of monoamine oxidase inhibitors by artificial intelligence and cheminformatics approach. ACS Omega 6(1):23399\u201323411. https:\/\/doi.org\/10.1021\/acsomega.1c03250","journal-title":"ACS Omega"},{"key":"663_CR4","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.1073\/pnas.0710626105","volume":"105","author":"S-Y Son","year":"2008","unstructured":"Son S-Y, Ma J, Kondou Y et al (2008) Structure of human monoamine oxidase A at 2.2-A resolution: the control of opening the entry for substrates\/inhibitors. Proc Natl Acad Sci U S A 105:5739\u20135744. https:\/\/doi.org\/10.1073\/pnas.0710626105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"663_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nsb732","volume":"9","author":"C Binda","year":"2002","unstructured":"Binda C, Newton-Vinson P, Hub\u00e1lek F et al (2002) Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat Struct Biol 9:22\u201326. https:\/\/doi.org\/10.1038\/nsb732","journal-title":"Nat Struct Biol"},{"key":"663_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202200084","volume":"355","author":"ST Sudevan","year":"2022","unstructured":"Sudevan ST, Rangarajan TM, Al-Sehemi AG et al (2022) Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase-B inhibitors. Arch Pharm (Weinheim) 355:e2200084. https:\/\/doi.org\/10.1002\/ardp.202200084","journal-title":"Arch Pharm (Weinheim)"},{"key":"663_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2024.101326","volume":"7","author":"C Shekhar Yadav","year":"2024","unstructured":"Shekhar Yadav C, Azad I, Rahman Khan A et al (2024) Recent advances in the synthesis of pyrazoline derivatives from chalcones as potent pharmacological agents: A comprehensive review. Results in Chemistry 7:101326. https:\/\/doi.org\/10.1016\/j.rechem.2024.101326","journal-title":"Results in Chemistry"},{"key":"663_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2174\/1871524915666151002124443","volume":"16","author":"B Mathew","year":"2016","unstructured":"Mathew B, Haridas A, Suresh J et al (2016) Monoamine oxidase inhibitory action of chalcones: a mini review. CNSAMC 16:120\u2013136. https:\/\/doi.org\/10.2174\/1871524915666151002124443","journal-title":"CNSAMC"},{"key":"663_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/cbdd.13919","volume":"98","author":"VP Koyiparambath","year":"2021","unstructured":"Koyiparambath VP, Prayaga Rajappan K, Rangarajan TM et al (2021) Deciphering the detailed structure\u2013activity relationship of coumarins as monoamine oxidase enzyme inhibitors\u2014an updated review. Chem Biol Drug Des 98:655\u2013673. https:\/\/doi.org\/10.1111\/cbdd.13919","journal-title":"Chem Biol Drug Des"},{"key":"663_CR10","doi-asserted-by":"publisher","first-page":"2300091","DOI":"10.1002\/ardp.202300091","volume":"356","author":"F Benny","year":"2023","unstructured":"Benny F, Kumar S, Jayan J et al (2023) Review of \u03b2-carboline and its derivatives as selective MAO-A inhibitors. Arch Pharm 356:2300091. https:\/\/doi.org\/10.1002\/ardp.202300091","journal-title":"Arch Pharm"},{"key":"663_CR11","doi-asserted-by":"publisher","first-page":"16244","DOI":"10.1021\/acsomega.2c01470","volume":"7","author":"S Kumar","year":"2022","unstructured":"Kumar S, Nair AS, Abdelgawad MA, Mathew B (2022) Exploration of the detailed structure-activity relationships of Isatin and their isomers as monoamine oxidase inhibitors. ACS Omega 7:16244\u201316259. https:\/\/doi.org\/10.1021\/acsomega.2c01470","journal-title":"ACS Omega"},{"key":"663_CR12","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/med.21561","volume":"39","author":"RKP Tripathi","year":"2019","unstructured":"Tripathi RKP, Ayyannan SR (2019) Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: an overview and update. Med Res Rev 39:1603\u20131706. https:\/\/doi.org\/10.1002\/med.21561","journal-title":"Med Res Rev"},{"key":"663_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/17460441.2019.163741","volume":"14","author":"P Guglielmi","year":"2019","unstructured":"Guglielmi P, Carradori S, Ammazzalorso A, Secci D (2019) Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement? Expert Opin Drug Discov 14:995\u20131035. https:\/\/doi.org\/10.1080\/17460441.2019.163741","journal-title":"Expert Opin Drug Discov"},{"key":"663_CR14","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1021\/acs.jpcb.6b09451","volume":"121","author":"B Mathew","year":"2017","unstructured":"Mathew B, Adeniyi AA, Dev S et al (2017) Pharmacophore-based 3D-QSAR analysis of thienyl chalcones as a new class of human MAO-B inhibitors: investigation of combined quantum chemical and molecular dynamics approach. J Phys Chem B 121:1186\u20131203. https:\/\/doi.org\/10.1021\/acs.jpcb.6b09451","journal-title":"J Phys Chem B"},{"key":"663_CR15","doi-asserted-by":"publisher","first-page":"11645","DOI":"10.1002\/slct.201701213","volume":"2","author":"B Mathew","year":"2017","unstructured":"Mathew B, Dev S, Joy M et al (2017) Refining the structural features of chromones as selective MAO-B inhibitors: exploration of combined pharmacophore-based 3D-QSAR and quantum chemical studies. ChemistrySelect 2:11645\u201311652. https:\/\/doi.org\/10.1002\/slct.201701213","journal-title":"ChemistrySelect"},{"key":"663_CR16","doi-asserted-by":"publisher","first-page":"42660","DOI":"10.1039\/C6RA00302H","volume":"6","author":"B Kumar","year":"2016","unstructured":"Kumar B, Sheetal S, Mantha AK, Kumar V (2016) Recent developments on the structure\u2013activity relationship studies of MAO inhibitors and their role in different neurological disorders. RSC Adv 6:42660\u201342683. https:\/\/doi.org\/10.1039\/C6RA00302H","journal-title":"RSC Adv"},{"key":"663_CR17","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.2174\/092986711797636090","volume":"18","author":"D Secci","year":"2011","unstructured":"Secci D, Bolasco A, Chimenti P, Carradori S (2011) The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant\/anticonvulsant agents. Curr Med Chem 18:5114\u20135144. https:\/\/doi.org\/10.2174\/092986711797636090","journal-title":"Curr Med Chem"},{"key":"663_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2174\/1871524914666140129122632","volume":"13","author":"B Mathew","year":"2013","unstructured":"Mathew B, Suresh J, Anbazhagan S, Mathew GE (2013) Pyrazoline: a promising scaffold for the inhibition of monoamine oxidase. Cent Nerv Syst Agents Med Chem 13:195\u2013206. https:\/\/doi.org\/10.2174\/1871524914666140129122632","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"663_CR19","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.2174\/156802612805220002","volume":"12","author":"M Joao Matos","year":"2012","unstructured":"Joao Matos M, Vina D, Vazquez-Rodriguez S et al (2012) Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold. Curr Top Med Chem 12:2210\u20132239. https:\/\/doi.org\/10.2174\/156802612805220002","journal-title":"Curr Top Med Chem"},{"key":"663_CR20","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1021\/jm801496u","volume":"52","author":"F Chimenti","year":"2009","unstructured":"Chimenti F, Secci D, Bolasco A et al (2009) Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. J Med Chem 52:1935\u20131942. https:\/\/doi.org\/10.1021\/jm801496u","journal-title":"J Med Chem"},{"key":"663_CR21","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s10904-023-02666-0","volume":"33","author":"S Bugalia","year":"2023","unstructured":"Bugalia S, Dhayal Y, Sachdeva H et al (2023) Review on isatin- a remarkable scaffold for designing potential therapeutic complexes and its macrocyclic complexes with transition metals. J Inorg Organomet Polym 33:1782\u20131801. https:\/\/doi.org\/10.1007\/s10904-023-02666-0","journal-title":"J Inorg Organomet Polym"},{"key":"663_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1590\/S0103-50532001000300002","volume":"12","author":"JFMD Silva","year":"2001","unstructured":"Silva JFMD, Garden SJ, Pinto AC (2001) The chemistry of isatins: a review from 1975 to 1999. J Braz Chem Soc 12:273\u2013324. https:\/\/doi.org\/10.1590\/S0103-50532001000300002","journal-title":"J Braz Chem Soc"},{"key":"663_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.627272","volume":"7","author":"RE Ferraz De Paiva","year":"2021","unstructured":"Ferraz De Paiva RE, Vieira EG, Rodrigues Da Silva D et al (2021) Anticancer Compounds Based on Isatin-Derivatives: Strategies to Ameliorate Selectivity and Efficiency. Front Mol Biosci 7:627272. https:\/\/doi.org\/10.3389\/fmolb.2020.627272","journal-title":"Front Mol Biosci"},{"key":"663_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1871524917666171113124112","volume":"18","author":"RS Cheke","year":"2018","unstructured":"Cheke RS, Firke SD, Patil RR, Bari SB (2018) ISATIN: New hope against convulsion. CNSAMC 18:76\u2013101. https:\/\/doi.org\/10.2174\/1871524917666171113124112","journal-title":"CNSAMC"},{"key":"663_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0928-0987(02)00077-5","volume":"16","author":"SK Sridhar","year":"2002","unstructured":"Sridhar SK, Pandeya SN, Stables JP, Ramesh A (2002) Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives. Eur J Pharm Sci 16:129\u2013132. https:\/\/doi.org\/10.1016\/S0928-0987(02)00077-5","journal-title":"Eur J Pharm Sci"},{"key":"663_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/10253890500342321","volume":"8","author":"A Medvedev","year":"2005","unstructured":"Medvedev A, Igosheva N, Crumeyrolle-Arias M, Glover V (2005) Isatin: role in stress and anxiety: review. Stress 8:175\u2013183. https:\/\/doi.org\/10.1080\/10253890500342321","journal-title":"Stress"},{"key":"663_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jphotobiol.2018.04.029","volume":"183","author":"AG Bharathi Dileepan","year":"2018","unstructured":"Bharathi Dileepan AG, Daniel Prakash T, Ganesh Kumar A et al (2018) Isatin based macrocyclic Schiff base ligands as novel candidates for antimicrobial and antioxidant drug design: in vitro DNA binding and biological studies. J Photochem Photobiol, B 183:191\u2013200. https:\/\/doi.org\/10.1016\/j.jphotobiol.2018.04.029","journal-title":"J Photochem Photobiol, B"},{"key":"663_CR28","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41598-024-51728-x","volume":"14","author":"S Kumar","year":"2024","unstructured":"Kumar S, Oh JM, Prabhakaran P et al (2024) Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect. Sci Rep 14:1264. https:\/\/doi.org\/10.1038\/s41598-024-51728-x","journal-title":"Sci Rep"},{"key":"663_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1039\/C8MD00585K","volume":"10","author":"S Varun","year":"2019","unstructured":"Varun S, Kakkar R (2019) Isatin and its derivatives: a survey of recent syntheses, reactions, and applications. Med Chem Commun 10:351\u2013368. https:\/\/doi.org\/10.1039\/C8MD00585K","journal-title":"Med Chem Commun"},{"key":"663_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/chin.201341251","volume":"44","author":"GS Singh","year":"2013","unstructured":"Singh GS, Desta ZY (2013) Cheminform abstract: applications of isatin chemistry in organic synthesis and medicinal chemistry. ChemInform 44:chin.201341251. https:\/\/doi.org\/10.1002\/chin.201341251","journal-title":"ChemInform"},{"key":"663_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/biof.1408","volume":"44","author":"A Medvedev","year":"2018","unstructured":"Medvedev A, Buneeva O, Gnedenko O et al (2018) Isatin, an endogenous nonpeptide biofactor: a review of its molecular targets, mechanisms of actions, and their biomedical implications. BioFactors 44:95\u2013108. https:\/\/doi.org\/10.1002\/biof.1408","journal-title":"BioFactors"},{"key":"663_CR32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1039\/D3RA90123H","volume":"14","author":"F Benny","year":"2024","unstructured":"Benny F, Oh JM, Kumar S et al (2024) Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurodegenerative disease treatment. RSC Adv 14:538\u2013538. https:\/\/doi.org\/10.1039\/D3RA90123H","journal-title":"RSC Adv"},{"key":"663_CR33","doi-asserted-by":"publisher","first-page":"12615","DOI":"10.1021\/jp906352e","volume":"113","author":"Y Lu","year":"2009","unstructured":"Lu Y, Wang Y, Xu Z et al (2009) C\u2212X\u00b7\u00b7\u00b7H contacts in biomolecular systems: how they contribute to protein\u2212ligand binding affinity. J Phys Chem B 113:12615\u201312621. https:\/\/doi.org\/10.1021\/jp906352e","journal-title":"J Phys Chem B"},{"key":"663_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116180","volume":"267","author":"S Sblano","year":"2024","unstructured":"Sblano S, Boccarelli A, Mesiti F et al (2024) A second life for MAO inhibitors? From CNS diseases to anticancer therapy. Eur J Med Chem 267:116180. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116180","journal-title":"Eur J Med Chem"},{"key":"663_CR35","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1021\/jm3012068","volume":"56","author":"R Wilcken","year":"2013","unstructured":"Wilcken R, Zimmermann MO, Lange A et al (2013) Principles and applications of halogen bonding in medicinal chemistry and chemical biology. J Med Chem 56:1363\u20131388. https:\/\/doi.org\/10.1021\/jm3012068","journal-title":"J Med Chem"},{"key":"663_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1517\/17460441.2012.678829","volume":"7","author":"Y Lu","year":"2012","unstructured":"Lu Y, Liu Y, Xu Z et al (2012) Halogen bonding for rational drug design and new drug discovery. Expert Opin Drug Discov 7:375\u2013383. https:\/\/doi.org\/10.1517\/17460441.2012.678829","journal-title":"Expert Opin Drug Discov"},{"key":"663_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00894-006-0130-2","volume":"13","author":"T Clark","year":"2007","unstructured":"Clark T, Hennemann M, Murray JS, Politzer P (2007) Halogen bonding: the \u03c3-hole: Proceedings of \u201cModeling interactions in biomolecules II\u201d, Prague, September 5th\u20139th, 2005. J Mol Model 13:291\u2013296. https:\/\/doi.org\/10.1007\/s00894-006-0130-2","journal-title":"J Mol Model"},{"key":"663_CR38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00894-006-0154-7","volume":"13","author":"P Politzer","year":"2007","unstructured":"Politzer P, Lane P, Concha MC et al (2007) An overview of halogen bonding. J Mol Model 13:305\u2013311. https:\/\/doi.org\/10.1007\/s00894-006-0154-7","journal-title":"J Mol Model"},{"key":"663_CR39","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1039\/C2CC37584B","volume":"49","author":"M Kol\u00e1\u0159","year":"2013","unstructured":"Kol\u00e1\u0159 M, Hobza P, Bronowska AK (2013) Plugging the explicit \u03c3-holes in molecular docking. Chem Commun 49:981\u2013983. https:\/\/doi.org\/10.1039\/C2CC37584B","journal-title":"Chem Commun"},{"key":"663_CR40","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1021\/acs.chemrev.5b00484","volume":"116","author":"G Cavallo","year":"2016","unstructured":"Cavallo G, Metrangolo P, Milani R et al (2016) The halogen bond. Chem Rev 116:2478\u20132601. https:\/\/doi.org\/10.1021\/acs.chemrev.5b00484","journal-title":"Chem Rev"},{"key":"663_CR41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2174\/0929867327666200121165931","volume":"28","author":"B Mathew","year":"2020","unstructured":"Mathew B, Carradori S, Guglielmi P et al (2020) New aspects of monoamine oxidase B inhibitors: the key role of halogens to open the golden door. CMC 28:266\u2013283. https:\/\/doi.org\/10.2174\/0929867327666200121165931","journal-title":"CMC"},{"key":"663_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejmech.2019.03.063","volume":"173","author":"W-Y Fang","year":"2019","unstructured":"Fang W-Y, Ravindar L, Rakesh KP et al (2019) Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: a critical review. Eur J Med Chem 173:117\u2013153. https:\/\/doi.org\/10.1016\/j.ejmech.2019.03.063","journal-title":"Eur J Med Chem"},{"key":"663_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13765-024-00917-3","volume":"67","author":"N Maliyakkal","year":"2024","unstructured":"Maliyakkal N, Oh JM, Kumar S et al (2024) Synthesis, biochemistry, and in silico investigations of isatin-based hydrazone derivatives as monoamine oxidase inhibitors. Appl Biol Chem 67:63. https:\/\/doi.org\/10.1186\/s13765-024-00917-3","journal-title":"Appl Biol Chem"},{"key":"663_CR44","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/cmdc.201500059","volume":"10","author":"S Mostert","year":"2015","unstructured":"Mostert S, Petzer A, Petzer JP (2015) Indanones as high-potency reversible inhibitors of Monoamine Oxidase. ChemMedChem 10:862\u2013873. https:\/\/doi.org\/10.1002\/cmdc.201500059","journal-title":"ChemMedChem"},{"key":"663_CR45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.taap.2011.12.005","volume":"258","author":"A Petzer","year":"2012","unstructured":"Petzer A, Harvey BH, Wegener G, Petzer JP (2012) Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase. Toxicol Appl Pharmacol 258:403\u2013409. https:\/\/doi.org\/10.1016\/j.taap.2011.12.005","journal-title":"Toxicol Appl Pharmacol"},{"key":"663_CR46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","volume":"38","author":"L Di","year":"2003","unstructured":"Di L, Kerns EH, Fan K et al (2003) High throughput artificial membrane permeability assay for blood\u2013brain barrier. Eur J Med Chem 38:223\u2013232. https:\/\/doi.org\/10.1016\/S0223-5234(03)00012-6","journal-title":"Eur J Med Chem"},{"key":"663_CR47","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"663_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105472","volume":"117","author":"A Mah\u00eda","year":"2021","unstructured":"Mah\u00eda A, Pe\u00f1a-D\u00edaz S, Navarro S et al (2021) Design, synthesis and structure-activity evaluation of novel 2-pyridone-based inhibitors of \u03b1-synuclein aggregation with potentially improved BBB permeability. Bioorg Chem 117:105472. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105472","journal-title":"Bioorg Chem"},{"key":"663_CR49","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/jcc.27390","volume":"45","author":"M Kabier","year":"2024","unstructured":"Kabier M, Gambacorta N, Trisciuzzi D et al (2024) MzDOCK\u202f: A free ready-to-use GUI -based pipeline for molecular docking simulations. J Comput Chem 45:1980\u20131986. https:\/\/doi.org\/10.1002\/jcc.27390","journal-title":"J Comput Chem"},{"key":"663_CR50","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1080\/07391102.2023.2214216","volume":"42","author":"S Kumar","year":"2024","unstructured":"Kumar S, Jayan J, Manoharan A et al (2024) Discerning of isatin-based monoamine oxidase (MAO) inhibitors for neurodegenerative disorders by exploiting 2D, 3D-QSAR modelling and molecular dynamics simulation. J Biomol Struct Dyn 42:2328\u20132340. https:\/\/doi.org\/10.1080\/07391102.2023.2214216","journal-title":"J Biomol Struct Dyn"},{"key":"663_CR51","doi-asserted-by":"publisher","first-page":"6167","DOI":"10.3390\/molecules28166167","volume":"28","author":"A Manoharan","year":"2023","unstructured":"Manoharan A, Oh JM, Benny F et al (2023) Assembling a cinnamyl pharmacophore in the C3-position of substituted isatins via microwave-assisted synthesis: development of a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson\u2019s disease. Molecules 28:6167. https:\/\/doi.org\/10.3390\/molecules28166167","journal-title":"Molecules"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00663-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00663-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00663-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:56:14Z","timestamp":1762451774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00663-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00663-8","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"84"}}